No abstract available
Keywords:
BCL6; immunochemotherapy; oncogenic programs; pSTAT6; sensitization.
MeSH terms
-
Antibodies, Monoclonal, Murine-Derived / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Cyclophosphamide / therapeutic use
-
Doxorubicin / therapeutic use
-
Female
-
Genetic Heterogeneity*
-
Humans
-
Lymphoma, B-Cell / genetics*
-
Lymphoma, B-Cell / therapy*
-
Mediastinal Neoplasms / genetics*
-
Mediastinal Neoplasms / therapy*
-
Oncogenes*
-
Prednisone / therapeutic use
-
Rituximab
-
Secondary Prevention
-
Vincristine / therapeutic use
Substances
-
Antibodies, Monoclonal, Murine-Derived
-
R-CHOP protocol
-
Rituximab
-
Vincristine
-
Doxorubicin
-
Cyclophosphamide
-
Prednisone